The U.S. Food and Drug Administration today announced its approval of genetically engineered salmon.
The FDA decision pertains specifically to a line of fish known as AquAdvantage salmon, from Massachusetts-based AquaBounty Technologies Inc.
Here's the FDA's main determination:
After an exhaustive and rigorous scientific review, FDA has arrived at the decision that AquAdvantage salmon is as safe to eat as any non-genetically engineered (GE) Atlantic salmon, and also as nutritious.
The agency added:
FDA assessed the environmental impacts of approving this application and found that the approval would not have a significant impact on the environment of the United States. That's because the multiple containment measures the company will use in the land-based facilities in Panama and Canada make it extremely unlikely that the fish could escape and establish themselves in the wild.